JPS62274000A - Substance h-13-2 - Google Patents

Substance h-13-2

Info

Publication number
JPS62274000A
JPS62274000A JP61119626A JP11962686A JPS62274000A JP S62274000 A JPS62274000 A JP S62274000A JP 61119626 A JP61119626 A JP 61119626A JP 11962686 A JP11962686 A JP 11962686A JP S62274000 A JPS62274000 A JP S62274000A
Authority
JP
Japan
Prior art keywords
substance
reagent
chloroform
methanol
soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP61119626A
Other languages
Japanese (ja)
Inventor
Chiyousei Seki
戚 長菁
Kiyoshi Den
田 潔
Teruyoshi Marunaka
丸中 照義
Ichiro Yamawaki
一郎 山脇
Toshio Otani
大谷 敏夫
Yoshinori Minami
南 慶典
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Priority to JP61119626A priority Critical patent/JPS62274000A/en
Publication of JPS62274000A publication Critical patent/JPS62274000A/en
Pending legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

NEW MATERIAL:A substance H-13-2 having the following physico-chemical properties. Melting point; 157-159 deg.C. Elementary analysis (%); C, 57.56; H, 9.07; N, 11.89. Contained amino acids; Alanine, proline and isoleucine. Specific rotatory power [alpha]<20>D=-31.3 (C=0.03, chloroform). Soluble in methanol, ethanol, chloroform, ethyl acetate and dimethyl sulfoxide, sparingly soluble in water and diethyl ether and insoluble in hexane. Molecular weight; 1205 (fast atom bombardment mass spectroscopy method). Positive to the sulfuric acid and iodine vapor and negative to hydrazine reagent, cerium sulfate reagent, Ehrlich regent and ninhydrin reagent. Neutral substance. White power. USE:An antimicrobial agent and carcinostatic agent PREPARATION:A microorganism, belonging to the genus Trichoderma and capable of producing the substance H-13-2 (FERM PBP-1009) is cultivated in culture medium at 5-6 pH and 20-40 deg.C for 4-8 days by a submerged culture method with aeration.

Description

【発明の詳細な説明】 発明の詳細な説明 産業上の利用分野 本発明は新規H−13−2物質に関するものである。本
発明のH−13−2物質は、抗菌作用、抗真菌作用及び
制癌作用を有しており医薬として有用である 従来の技術 本発明のH−13−2物質は文献未記載の新規物質であ
る。
DETAILED DESCRIPTION OF THE INVENTION Field of the Invention The present invention relates to a novel H-13-2 substance. The H-13-2 substance of the present invention has antibacterial, antifungal, and anticancer effects and is useful as a medicine.Conventional technology The H-13-2 substance of the present invention is a novel substance that has not been described in any literature. It is.

発明が解決しようとする問題点 本発明の目的は、抗菌作用、抗真菌作用及び制癌作用を
有する新規物質を提供することにある。
Problems to be Solved by the Invention An object of the present invention is to provide a new substance having antibacterial, antifungal, and anticancer effects.

問題点を解決するための手段 上記目的は、下記本発明物質により達成される。Means to solve problems The above object is achieved by the substance of the present invention described below.

本発明のH−13−2物質は、次の理化学的性質を有す
る。
The H-13-2 substance of the present invention has the following physical and chemical properties.

(a)融点:157〜159°C0 (b)元素分析:0 57.56%、 H9,07%、N  11.89%。(a) Melting point: 157-159°C0 (b) Elemental analysis: 0 57.56%, H9.07%, N 11.89%.

(C)含有するアミノ酸:アラニン、プロリン、イソロ
イシン。
(C) Containing amino acids: alanine, proline, isoleucine.

(d)比旋光度:[α]20=−31,3(C=0.0
3、クロロホルム中〉。
(d) Specific rotation: [α]20=-31,3 (C=0.0
3. In chloroform>.

(e)紫外吸収スペクトル、メタノール中λ(nm):
220〜360で特徴的な吸収ヲ示さない。チャートを
第1図に示す。
(e) Ultraviolet absorption spectrum, λ (nm) in methanol:
No characteristic absorption is shown between 220 and 360. The chart is shown in Figure 1.

Br (f>赤外吸収スペクトル、ν  (cm−1):ma
× 3330.2940.1675.1539.1465.
1396゜チャートを第2図に示す。
Br (f > infrared absorption spectrum, ν (cm-1): ma
× 3330.2940.1675.1539.1465.
A 1396° chart is shown in Figure 2.

(Cl)溶解性:メタノール、エタノール、クロロホル
ム、酢酸エチルエステル、ジメチルスルホキシドによく
溶ける。水、ジエヂルエーテルに難溶で、ヘキサンに不
溶である。
(Cl) Solubility: Well soluble in methanol, ethanol, chloroform, acetic acid ethyl ester, and dimethyl sulfoxide. Slightly soluble in water and diethyl ether, and insoluble in hexane.

(h)分子ffl:1205(ファースト アトミック
 ボンバードメント マススペクトロメトリー法による
。)。
(h) Molecule ffl: 1205 (by fast atomic bombardment mass spectrometry).

(i>¥色反応:fiM酸、ヨード蒸気に陽性、ヒドラ
ジン試薬、硫酸セリウム試薬、エールリッヒ試薬、ニン
ヒドリン試薬に陰性。
(i>¥ Color reaction: positive for fiM acid, iodine vapor, negative for hydrazine reagent, cerium sulfate reagent, Ehrlich reagent, ninhydrin reagent.

(j)塩基性、酸性、中性の区別:中性物質。(j) Distinction between basic, acidic, and neutral: neutral substances.

(k)物質の色:白色粉末。(k) Color of substance: white powder.

本発明のH−13−2物質は、H−13−2物質の生産
能を有する微生物(以下、H−13−2物質生産菌と称
する。)を培地に培養し、得られる培養物からH−13
−2物質を分離、採取することにより製造することがで
きる。
The H-13-2 substance of the present invention is produced by culturing a microorganism capable of producing an H-13-2 substance (hereinafter referred to as an H-13-2 substance-producing bacterium) in a medium, and then producing H-13-2 from the resulting culture. -13
- Can be manufactured by separating and collecting two substances.

H−13−2物質生産菌の一例として、本発明者らが中
華人民共和国黒龍省の土壌から新たに分離したトリコデ
ルマ属に属するH−13菌株を挙げることができる。
An example of the H-13-2 substance-producing bacteria is the H-13 strain belonging to the genus Trichoderma, which the present inventors newly isolated from the soil of Heilong Province, People's Republic of China.

このH−13−2物質生産菌は、通商産業省工業技術院
微生物工業技術研究所に受託番号「微工研条奇第100
9号(FERM  BP−1009>jとして寄託され
ている。
This H-13-2 substance-producing bacterium was submitted to the Institute of Microbial Technology, Agency of Industrial Science and Technology, Ministry of International Trade and Industry, with the accession number "Feikoken Joki No. 100".
No. 9 (FERM BP-1009>j).

次に、本発明のH−13−2物質を、例えば上記のよう
なトリコデルマ屈に屈するH−13−2物質生産菌を培
地に培養することによって製造する場合について説明す
る。
Next, a case will be described in which the H-13-2 substance of the present invention is produced by culturing, for example, the above-mentioned H-13-2 substance-producing bacteria susceptible to Trichoderma in a medium.

培養方法は原則的には一般微生物の培養方法に準するが
、通常は液体培地による撹拌通気培養法が有利である。
The culture method is basically based on the culture method of general microorganisms, but a stirring aeration culture method using a liquid medium is usually advantageous.

培養に用いられる培地としては、H−13−2物質生産
菌が利用できる栄養源を含有する培地であればよい。
The medium used for culture may be any medium containing a nutrient source that can be utilized by the H-13-2 substance producing bacteria.

すなわち、合成培地、半合成培地おるいは天然培地を用
いることができる。培地の組成は、炭素源としては、例
えばグルコース、マンノース、グリセリン、シュクロー
ス、糖蜜、でん粉、液化でん粉、有機酸などが単独また
は混合物として用いられる。窒素源としては、例えば大
豆粉、コーン・スチープ・リカー、肉エキス、酵母エキ
ス、綿実粉、ペプトン、小麦胚芽、!酸アンモニウム、
硝酸アンモニウムなどが単独または混合して用いられる
。無機塩としては、例えば炭酸カルシウム、塩化ナトリ
ウム、塩化カリウム、硝酸ナトリウム、硫酸マグネシウ
ム、塩化コバルト、各種リン酸塩などがあげられ、必要
に応じて培地に添加される。
That is, a synthetic medium, a semi-synthetic medium, or a natural medium can be used. Regarding the composition of the medium, carbon sources such as glucose, mannose, glycerin, sucrose, molasses, starch, liquefied starch, and organic acids are used singly or as a mixture. Examples of nitrogen sources include soybean flour, corn steep liquor, meat extract, yeast extract, cottonseed flour, peptone, wheat germ, and more! ammonium acid,
Ammonium nitrate and the like are used alone or in combination. Examples of inorganic salts include calcium carbonate, sodium chloride, potassium chloride, sodium nitrate, magnesium sulfate, cobalt chloride, and various phosphates, which are added to the medium as necessary.

また、培養中発泡の著しい時には、例えば大豆油、亜麻
仁油等の植物油、オクタデカノール等の高級アルコール
類、各種シリコン化合物等の消泡剤を適宜添加してもよ
い。
Further, when foaming is significant during culturing, antifoaming agents such as vegetable oils such as soybean oil and linseed oil, higher alcohols such as octadecanol, and various silicon compounds may be added as appropriate.

培養の際の培地のDHは約5〜6程度、培養温度は約2
0〜40’C程度に調節するとよい。培養時間は4〜8
日程度が適当である。また、大量生産を行なう場合には
、深部通気培養によるのが好ましい。
During culture, the DH of the medium is about 5 to 6, and the culture temperature is about 2.
It is best to adjust the temperature to about 0 to 40'C. Culture time is 4-8
Approximately one day is appropriate. In addition, when performing mass production, it is preferable to use deep aeration culture.

培養終了後、培養物からH−13−2物質を採取する方
法は、通常の発酵生産物を@養物から分離採取する際に
用いる方法に準する。例えば、ン濾過、遠心分離、各種
活性吸着剤による吸脱着やタロマドグラフィー、各種有
機溶媒による抽出、再結晶などを適宜組合せて行なうこ
とによりト1−13−2物質を得ることができる。
After the cultivation is completed, the method for collecting the H-13-2 substance from the culture is similar to the method used when separating and collecting ordinary fermentation products from nutrients. For example, the To1-13-2 substance can be obtained by performing a suitable combination of filtration, centrifugation, adsorption/desorption using various active adsorbents, talomadography, extraction using various organic solvents, recrystallization, and the like.

かくして得られる本発明のH−13−2物質は、ダラム
陽性菌、ダラム陰性菌及び酵母、かび等の真菌類に広く
抗菌スペクトラムを有する。また、本発明H−13−2
物質は、制癌作用をも有している。
The H-13-2 substance of the present invention thus obtained has a broad antibacterial spectrum against Durum-positive bacteria, Durum-negative bacteria, and fungi such as yeast and mold. In addition, the present invention H-13-2
The substance also has anticancer properties.

本発明のH−13−2物質の抗菌活性をダラム陽性、陰
性菌では栄養寒天培地を用い、また真菌類についてはサ
ブロー寒天培地を用いて2系列2倍希釈法により、最少
発育阻止濃度(M、I。
The antibacterial activity of the H-13-2 substance of the present invention was determined by the minimum inhibitory concentration (M ,I.

C,)で測定した。結果を第1表に示す。C,). The results are shown in Table 1.

弔1表 実施例 次に、実施例を挙げて更に詳細に説明する。Condolence table 1 Example Next, a more detailed explanation will be given with reference to examples.

実施例 液体培地(ポテト抽出液(ボテl−スライス1009を
脱イオン水500IrlQで15分煮沸し、ガービで固
形分を除いたもの)、グルコース2%、DH5,5)を
500m12容三角フラスコ5本に100 mQずつ分
注し、120’Cl2O分間A−トクレープで殺菌後、
ポデト寒天培地上で発育したH−13−2物質生産菌(
微工研条奇第1009号)の胞子及び菌糸体を接種し、
27°Cで2日間回転振どう培養(毎分180回転、1
0cm)して前培養液を作成した。次に、グルコース4
.0%、ソイトン0.5%、硝酸ナトウリム0.3%、
リン酸二水素カリ1クム0.2%、塩化カリウム0.0
5%、硫酸マグネシウム0.05%、硫酸第二鉄090
03%の組成よりなる液体培地(1))−15,5>1
00mQずつを同様に分注後、120’Cl2O分間オ
ートクレーブで殺菌した5 00 mQ容三角フラスコ
80本に、上記前培養液の5 mQを種菌として植菌し
、27°Cで5〜6日間回転振どう培養(毎分180回
転、10ra>を行なった。
Example liquid medium (potato extract (boiled Botel Slice 1009 in deionized water 500IrlQ for 15 minutes and removed solids with Gavi), glucose 2%, DH 5.5) was added to five 500m 12 Erlenmeyer flasks. After dispensing 100 mQ each into
H-13-2 substance producing bacteria grown on Podeto agar medium (
Inoculated with spores and mycelium of ``Feikokenjoki No. 1009'',
Rotary shaking culture at 27°C for 2 days (180 revolutions per minute, 1
0 cm) to prepare a preculture solution. Next, glucose 4
.. 0%, soyton 0.5%, sodium nitrate 0.3%,
Potassium dihydrogen phosphate 1 cum 0.2%, potassium chloride 0.0
5%, magnesium sulfate 0.05%, ferric sulfate 090
Liquid medium with a composition of 0.3% (1))-15,5>1
After dispensing 00 mQ each in the same manner, 5 mQ of the above preculture solution was inoculated as a seed into 80 500 mQ Erlenmeyer flasks that had been sterilized by autoclaving for 120' Cl2O, and rotated at 27°C for 5 to 6 days. Shaking culture (180 revolutions per minute, 10 ra) was performed.

培養液を濾過し、残った菌体をメタノール1.5して抽
出した。メタノール抽出液を濃縮し、残漬を酢酸エチル
エステルで0.2Lずつ2回抽出後、酢酸エチルエステ
ル抽出液を水洗した。培養炉液については酢酸エチルエ
ステル5Lずつで2回抽出し、抽出液を水洗後、先の菌
体側の酢酸エチルエステル抽出液と合わせて、無水@酸
ナトリウムで乾燥後、濃縮し、得られた油状物をシリカ
ゲルカラムクロマトグラフィー(メルり社製、キーゼル
ゲル、5.9X19cm>(クロロホルム:メタノール
=5:1)にかけ、活性成分を分取した。分取した活性
成分を再度シリカゲルカラムクロマトグラフィー(メル
ク社製、キーゼルゲル、5.9X19cm>(酢酸エチ
ルエステル:メタノール=5 : 1 )にかけ活性成
分を分取した。分取した活性成分をアセトニトリルより
再結晶して、白色粉末のH−13−2物質98m!Jを
得た。また、活性成分の指標としては、スタフィロコッ
カスアウレウス 209 P (5taphyloco
ccus aureus209P)を用いた。
The culture solution was filtered, and the remaining bacterial cells were extracted with 1.5 methanol. The methanol extract was concentrated, and the residue was extracted twice with 0.2 L each with ethyl acetate, and then the ethyl acetate extract was washed with water. The culture solution was extracted twice with 5 L of ethyl acetate each time, and the extract was washed with water, combined with the ethyl acetate extract from the bacterial cell side, dried over anhydrous sodium chloride, and concentrated to obtain the extract. The oily substance obtained was subjected to silica gel column chromatography (manufactured by Merli Co., Ltd., Kieselgel, 5.9 x 19 cm> (chloroform:methanol = 5:1) to separate the active components.The separated active components were again subjected to silica gel column chromatography ( The active ingredient was separated by applying Kieselgel, 5.9 x 19 cm (manufactured by Merck & Co., Ltd.) (acetic acid ethyl ester: methanol = 5:1).The separated active ingredient was recrystallized from acetonitrile, and a white powder of H-13-2 was added. The substance 98m!J was obtained.As an indicator of the active ingredient, Staphylococcus aureus 209P (5taphylococcus aureus
ccus aureus 209P) was used.

【図面の簡単な説明】[Brief explanation of drawings]

第1図はH−13−2物質のメタノール中での紫外吸収
スペクトルを、第2図はl−1−13−2物質の臭化カ
リウム錠で測定した赤外吸収スペクトルをそれぞれ示す
。 (以 上)
FIG. 1 shows the ultraviolet absorption spectrum of substance H-13-2 in methanol, and FIG. 2 shows the infrared absorption spectrum of substance 1-1-13-2 measured with a potassium bromide tablet. (that's all)

Claims (1)

【特許請求の範囲】[Claims] (1)下記の理化学的性質を有する新規H−13−2物
質。 (a)融点:157〜159℃。 (b)元素分析:C57.56%、 H9.07%、N11.89%。 (c)含有するアミノ酸:アラニン、プロリン、イソロ
イシン。 (d)比旋光度:[α]^2^0_D=−31.3(C
=0.03、クロロホルム中)。 (e)紫外吸収スペクトル、メタノール中λ(nm):
220〜360で特徴的な吸収を示さない。チャートを
第1図に示す。 (f)赤外吸収スペクトル、ν^K^B^r_m_a_
x(cm^−^1):3330、2940、1675、
1539、1465、1396。チャートを第2図に示
す。 (g)溶解性:メタノール、エタノール、クロロホルム
、酢酸エチルエステル、ジメチルスルホキシドによく溶
ける。水、ジエチルエーテルに難溶で、ヘキサンに不溶
である。 (h)分子量:1205(ファーストアトミックボンバ
ードメントマススペクトロメ トリー法による。)。 (i)呈色反応:硫酸、ヨード蒸気に陽性、ヒドラジン
試薬、硫酸セリウム試薬、エールリッヒ試薬、ニンヒド
リン試薬に陰性。 (j)塩基性、酸性、中性の区別:中性物質。 (k)物質の色:白色粉末。
(1) A novel H-13-2 substance having the following physical and chemical properties. (a) Melting point: 157-159°C. (b) Elemental analysis: C57.56%, H9.07%, N11.89%. (c) Containing amino acids: alanine, proline, isoleucine. (d) Specific rotation: [α]^2^0_D=-31.3(C
= 0.03 in chloroform). (e) Ultraviolet absorption spectrum, λ (nm) in methanol:
No characteristic absorption is shown between 220 and 360. The chart is shown in Figure 1. (f) Infrared absorption spectrum, ν^K^B^r_m_a_
x (cm^-^1): 3330, 2940, 1675,
1539, 1465, 1396. The chart is shown in Figure 2. (g) Solubility: Well soluble in methanol, ethanol, chloroform, acetic acid ethyl ester, and dimethyl sulfoxide. Slightly soluble in water and diethyl ether, and insoluble in hexane. (h) Molecular weight: 1205 (according to fast atomic bombardment mass spectrometry). (i) Color reaction: positive for sulfuric acid and iodine vapor, negative for hydrazine reagent, cerium sulfate reagent, Ehrlich's reagent, and ninhydrin reagent. (j) Distinction between basic, acidic, and neutral: neutral substances. (k) Color of substance: white powder.
JP61119626A 1986-05-23 1986-05-23 Substance h-13-2 Pending JPS62274000A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61119626A JPS62274000A (en) 1986-05-23 1986-05-23 Substance h-13-2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61119626A JPS62274000A (en) 1986-05-23 1986-05-23 Substance h-13-2

Publications (1)

Publication Number Publication Date
JPS62274000A true JPS62274000A (en) 1987-11-28

Family

ID=14766100

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61119626A Pending JPS62274000A (en) 1986-05-23 1986-05-23 Substance h-13-2

Country Status (1)

Country Link
JP (1) JPS62274000A (en)

Similar Documents

Publication Publication Date Title
JPH01112989A (en) Ab-006 antibiotic substance and method for its manufacture
JPS6254433B2 (en)
JPS62274000A (en) Substance h-13-2
JPS61282087A (en) Novel substance no.8345-a
JPS61212587A (en) G0069lambda substance
KR830000618B1 (en) Preparation method of new antibiotic SF-2050B
JPS589676B2 (en) Nojirimycin B
JPS5932120B2 (en) Method for producing 9-β-D arabinofuranosyl adenine
JPS6272691A (en) Novel physiologically active substance no.1328 and production thereof
JPS63192792A (en) Novel antibiotic sf 2487 substance and production thereof
JPS6246551B2 (en)
JPS5918035B2 (en) Antibiotic AB-85
JPS5828293A (en) Preparation of mitomycins
JPS6024195A (en) Production of psicofuranine
JPS61170396A (en) Novel carcinostatic antibiotic substance 83-16-a and preparation thereof
JPH0449291A (en) Bioactive substance fd-891
JPS6316391B2 (en)
JPS6046958B2 (en) New antibiotic SF-2049 substance and its manufacturing method
JPS6246550B2 (en)
JPS5951999B2 (en) New physiologically active substance betenone A and its production method
JPH04108787A (en) New 18-membered macrolide compound
JPS60126093A (en) Novel antibiotic substance ss7313b and its production
JPS61146188A (en) Antibiotic substance rk-419 and preparation thereof
JPH0531552B2 (en)
JP2003284587A (en) Method for producing yellow pigment